Clinical trial
Treatment of Psoriasis With Parathyroid Hormone
NCT00007306 · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH · Completed
Key facts
| NCT number | NCT00007306 |
|---|---|
| Title | Treatment of Psoriasis With Parathyroid Hormone |
| Official title | Evaluation of the Therapeutic Efficacy & Safety of Topical Administration of Parathyroid Hormone (PTH) in Psoriasis |
| Lead sponsor | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Plaque Psoriasis |
| Intervention type | Drug |
| Interventions | Parathyroid hormone ointment |
| Enrollment | 40 |
| Start date | Jan 1, 2000 |
| Completion | Apr 1, 2005 |
| First posted | Dec 18, 2000 |
| Last update posted | Jan 4, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: